ArticleJournal of translational medicine2014

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy.

Grazia Palomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.